Tagra Biotechnologies

Tagra Biotechnologies is a manufacturer and developer of cosmetic ingredients, microencapsulation technology, and skin delivery systems. The company is focused on using its technology to overcome technical challenges, with the goal of creating successful beauty products. Tagras ingredients are globally compliant; free of preservatives, surfactants, and allergens; Halal certified; non-nano-sized and compliant with nano regulations; and not tested on animals and free of any animal-derived materials. The companys microencapsulations create visual and sensory effects, such as color and texture transitions, designed to engage and delight the end consumer. In addition, its stabilized actives are delivered fresh with release on demand (RND) for improved anti-aging benefits.

Tagra Biotechnologies was founded in 1998 by Ron Folman, M.Sc. (Founder & CEO).

Tagra Biotechnologies operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Cosmetic Materials, with core technologies in Materials & Substances. Target customers: Healthcare & Life Sciences, Life Sciences, Cosmetics, Consumers, Demographics & Family, Women, Commerce & Retail, Consumer Goods, Beauty & Cosmetics.

Tagra Biotechnologies is based in HaMelacha Street 8, Netanya, Israel, Center District.